Skip to main content
. 2020 May 12;4(9):2095–2110. doi: 10.1182/bloodadvances.2020001755

Table 3.

Example of an SoF table

AAP compared with no AAP for pregnant women with prior VTE*
Outcomes No. of participants (studies) Certainty in the evidence (GRADE) Relative effect, RR (95% CI) Anticipated absolute effects
Risk with no AAP Risk difference with AAP
Recurrent major VTE (PE or proximal DVT) 1519 (11 observational studies)53§|| ⊕⊕◯◯ Low 0.39 (0.21-0.72) 42 per 1000 26 fewer per 1000 (33 fewer to 12 fewer)
Major bleeding, antepartum 943 (6 RCTs)54 ⊕⊕◯◯ Low# 0.34 (0.04-3.21) 6 per 1000 4 fewer per 1000 (6 fewer to 14 more)
Major peripartum bleed 799 (8 RCTs)54 ⊕⊕◯◯ Low# 0.82 (0.36-1.86) 30 per 1000 5 fewer per 1000 (19 fewer to 26 more)
Thrombocytopenia 945 (8 RCTs)54 ⊕◯◯◯ Very low#** 2.37 (0.92-6.11) 13 per 1000 17 more per 1000 (1 fewer to 64 more)

AAP, antepartum anticoagulant prophylaxis; RR, risk ratio; SoF, summary of findings.

*

Patient or population: pregnant women with prior VTE. Setting: inpatient or outpatient setting. Intervention: antepartum anticoagulant prophylaxis. Comparison: no antepartum anticoagulant prophylaxis.

GRADE Working Group grades of evidence: high certainty, we are very confident that the true effect lies close to that of the estimate of the effect; moderate certainty, we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different; low certainty, our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect; very low certainty, we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect.

The risk in the intervention group (and its 95% CI) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).

§

Total of 11 studies; 8 had a group that received antepartum prophylaxis; 9 had a group with no antepartum prophylaxis. Of the 11, 7 were retrospective, 4 were prospective (3 were randomized comparisons).

||

Provoked, unprovoked, or estrogen associated in LMWH.

Most women had a history of placenta-mediated pregnancy complications; none had a history of prior VTE.

#

The very low event rate leads to uncertainty.

**

Not a direct outcome of interest, which leads to uncertainty.